Eseandre Mordi
⬤ Shares of Hims & Hers Health surged to $16.48 after trading near the mid-$14 area earlier in the session, posting a 13.5% single-day gain. The move sharpens one central question: is this the start of a real recovery, or just a brief bounce inside a downtrend that is still very much intact?
⬤ The weekly chart tells the story clearly. The latest push higher came after a sharp selloff into early 2026, with price action reacting off a support level near $13.74. Demand appears to have returned following that test, with the week's range spanning roughly $14.31 to $16.48, closing near the highs. A recent technical breakdown noted how HIMS hovered around a multi-year support zone near $14.50 to $15 after a sharp decline, flagging that level as one worth watching closely.
⬤ The bigger picture, though, remains heavy. The stock sits about 76% below its 52-week high, and that gap underscores just how much ground HIMS would need to reclaim to fully repair the prior damage. Earlier coverage highlighted how Hims & Hers faced a make-or-break earnings moment after the stock plunged 50% to the $16 area, framing results and guidance as a critical inflection point for the name.
⬤ Whether this latest 13.5% session becomes the start of something more durable will hinge on follow-through. Another technical note drew attention to how a potential bullish crossover signal in HIMS followed a prior 92% rally, a momentum setup that traders tend to watch closely during reversal attempts. For now, the weekly close near session highs at least gives bulls something to work with.
Eseandre Mordi
